Winette van der Graaf, Founding member Common Sense Oncology (CSO) at Common Sense Oncology, shared on LinkedIn:
“Wednesday 18 Nov will be busy at the annual meeting of the Connective Tissue Oncology Society in Seoul with quite a couple of interesting pre-meetings!
For those of you interested in Patient Reported Outcome Research in sarcoma (PRO-Sarcoma) please feel free to join us at 4-6 pm KST in 2F room 209.
Great international collaboration over the years with meetings in Amsterdam and during CTOS in Dublin and San Diego.
New people very welcome of course.”
About CTOS 2026
The 2026 Connective Tissue Oncology Society (CTOS) Annual Meeting will take place on November 18–21, 2026, in Seoul, South Korea, bringing together leading clinicians, researchers, scientists, and healthcare professionals specializing in sarcoma and other connective tissue tumors.
The meeting provides an international platform to exchange scientific knowledge, discuss advances in diagnosis and treatment, and explore emerging approaches to sarcoma research and patient care. The scientific program covers a broad range of topics, including foundational sarcoma science, molecular mechanisms, clinical research, multidisciplinary treatment, and developments in rare cancers, alongside scientific presentations, poster discussions, and networking opportunities.
You can also read: OncoDaily Grand Rounds at ESMO 2026: Partners and Experts Advance the Sarcoma Conversation in Madrid
